Vir Biotechnology, Inc.VIRNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank50
3Y CAGR-65.1%
5Y CAGR+0.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-65.1%/yr
vs +556.9%/yr prior
5Y CAGR
+0.4%/yr
Recent deceleration
Acceleration
-622.0pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$68.56M-7.6%
2024$74.20M-13.9%
2023$86.18M-94.7%
2022$1.62B+47.5%
2021$1.10B+1529.0%
2020$67.25M+9357.8%
2019$711000.00-18.1%
2018$868000.00+482.6%
2017$149000.00-